AbbVie (ABBV) Raw Materials (2012 - 2016)

AbbVie has disclosed Raw Materials across 5 years of filings, most recently posting $132.0 million for Q2 2016.

• In Q2 2016, Raw Materials rose 4.76% year-over-year to $132.0 million; the TTM figure through Jun 2016 stood at $132.0 million (up 4.76% YoY), while the FY2015 annual figure was $169.0 million, up 9.74% from the prior year.
• Raw Materials eased to $132.0 million in Q2 2016, from $155.0 million in the prior quarter.
• Over the last five years, Raw Materials for ABBV reached as high as $261.0 million in Q4 2013 and fell as low as $126.0 million in Q2 2015.
• The 5-year median for Raw Materials is $163.0 million (2015), against an average of $188.2 million.
• The widest YoY moves for Raw Materials: up 9.74% in 2015, down 45.02% in 2015.
• A 5-year view of Raw Materials shows it stood at $258.0 million in 2012, then climbed by 1.16% to $261.0 million in 2013, then plunged by 41.0% to $154.0 million in 2014, then advanced by 9.74% to $169.0 million in 2015, then slipped by 21.89% to $132.0 million in 2016.
• According to Business Quant data, Raw Materials over the past three periods registered $132.0 million, $155.0 million, and $169.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.